ucsdhealthsciences: The Center for Medicinal Cannabis Research at University of California San Diego
ucsdhealthsciences: The Center for Medicinal Cannabis Research at University of California San Diego School of Medicine announces $3 million in research grants to explore new applications of cannabis for a number of novel medical applications. “Within the medical community, there is a lot of interest in the role of medical cannabis and CBD,” said Igor Grant, MD, Distinguished Professor in the Department of Psychiatry and CMCR director. “There is a hope that it could be yet another useful agent in some of these conditions, which are difficult to treat or disabling.” The five grants are funded by California Proposition 64, which was passed on the November 8, 2016 ballot and legalized recreational marijuana in the state. The measure allocated tax revenue for research on potential new drugs, treatment and health and safety programs related to marijuana and medical cannabis. This year marks CMCR’s first such funding. All five grants are for proof-of-principle studies that would seek to establish the basis for future research. Effects of Cannabidiol versus Placebo as an Adjunct to Treatment in Early Psychosis Therapeutic Response of Cannabidiol in Rheumatoid Arthritis Cannabidol for Sedative/Hypnotic-sparing Management of Insomnia in Adults Cannabidiol as a Strategy to Treat Alcohol Dependence The Role of Cannabidiol in Regulating Meal Time Anxiety in Anorexia Nervosa A second round of CMCR grants is scheduled for 2020. “UC San Diego’s Center for Medicinal Cannabis Research Awards Grants for Five Novel Studies“ -- source link
#cannabis research#medical#pain management